March 2026
1. QIN Y, Choi KY, El-Hamdi N, McGregor A, et al
   Knockout of key receptors (PDGFRA and NRP2) in the guinea pig model blocks direct and endocytic pathways of CMV cell entry.
   J Gen Virol. 2026;107:002236.
   

   >> Share

   
   
2. MARTIN-MARTIN C, Ruiz-Rico M, Barat JM, Garcia-Rios E, et al
   Decoding the antiviral potential of eugenol, thymol and vanillin against human cytomegalovirus infection.
   J Gen Virol. 2026;107:002248.
   

   >> Share

   
   January 2026
3. BEETON K, Haskell JP, Mitra D, Taylor EB, et al
   Optimizing delivery of an anti-cytomegalovirus inhibitory peptide using a cell-penetrating peptide.
   J Gen Virol. 2026;107:002210.
   

   >> Share

   
   December 2025
4. PINTO H, Latham KA, Goodbourn S, Witney AA, et al
   Repurposing of the bisbenzimide antibiotic Ridinilazole as an antiviral compound against human cytomegalovirus.
   J Gen Virol. 2025;106.
   

   >> Share

   
   November 2025
5. STRANG BL
   Inhibition of human cytomegalovirus replication by valaciclovir.
   J Gen Virol. 2025;106:002178.
   

   >> Share

   
   October 2025
6. BUSCHER N, Sinzger C, Lehmann C, Zimmermann C, et al
   Mutation of the nuclear localization signals of the major tegument protein pp65 leads to impairment of human cytomegalovirus progeny production.
   J Gen Virol. 2025;106.
   

   >> Share

   
   
7. DHOTRE K, Schutz M, von Essen S, Fortelny L, et al
   Conserved mode of nuclear lamina distortion by primate cytomegaloviruses: importance of the pSer22 motif, viral kinase and cis/trans isomerase Pin1 activity.
   J Gen Virol. 2025;106.
   

   >> Share

   
   July 2025
8. CARMICHAEL JC, Stevens CS, Atanasoff KE, Kowdle S, et al
   Precision engineering of human cytomegalovirus without BAC constraints: a Sendai virus-delivered CRISPR/Cas9 approach.
   J Gen Virol. 2025;106.
   

   >> Share

   
   April 2025
9. NUEVALOS GUAITA M, Jimoh TO, Barrall EB, Atanasoff KE, et al
   Characterization of human cytomegalovirus infection dynamics in human microglia.
   J Gen Virol. 2025;106:002096.
   

   >> Share

   
   August 2024
10. MA J, Bruce K, Stevenson PG, Farrell HE, et al
    Mouse cytomegalovirus lacking sgg1 shows reduced import into the salivary glands.
    J Gen Virol. 2024;105:002013.
    

    >> Share

    
    April 2024
11. HUNTER LM, Kite J, Fletcher-Etherington A, Nightingale K, et al
    HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L.
    J Gen Virol. 2024;105.
    

    >> Share

    
    January 2024
12. XIE W, Bruce K, Stevenson PG, Farrell HE, et al
    Indirect CD4(+) T cell protection against persistent MCMV infection by NK cells requires IFNgamma.
    J Gen Virol. 2024;105.
    

    >> Share

    
    December 2023
13. CHOWDHURY S, Latham KA, Tran AC, Carroll CJ, et al
    Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors.
    J Gen Virol. 2023;104.
    

    >> Share

    
    September 2023
14. PARSONS AJ, Stein KR, Atanasoff KE, Ophir SI, et al
    The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cells.
    J Gen Virol. 2023;104:001892.
    

    >> Share

    
    
15. MASON R, Bradley E, Wills M, Sinclair J, et al
    Repression of the major immediate early promoter of human cytomegalovirus allows transcription from an alternate promoter.
    J Gen Virol. 2023;104.
    

    >> Share

    
    August 2023
16. HANSEN F, Vucak M, Nichols J, Hughes J, et al
    Isolation and genome sequencing of cytomegaloviruses from Natal multimammate mice (Mastomys natalensis).
    J Gen Virol. 2023;104.
    

    >> Share

    
    June 2023
17. GOMES AC, Baraniak IA, McIntosh MR, Sodi I, et al
    A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' sera.
    J Gen Virol. 2023;104.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share